Macquarie Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15,036
Closed -$92K 2684
2021
Q3
$92K Buy
15,036
+10,857
+260% +$67.7K ﹤0.01% 2013
2021
Q2
$34K Buy
4,179
+3,796
+991% +$32.3K ﹤0.01% 2245
2021
Q1
$3K Sell
383
-59,080
-99% -$677K ﹤0.01% 2456
2020
Q4
$687K Sell
59,463
-4,670
-7% -$54.3K ﹤0.01% 1396
2020
Q3
$668K Sell
64,133
-2,358
-4% -$28.9K ﹤0.01% 1339
2020
Q2
$874K Buy
66,491
+1,765
+3% +$18.3K ﹤0.01% 1240
2020
Q1
$509K Buy
64,726
+3,764
+6% +$56.7K ﹤0.01% 1267
2019
Q4
$1.26M Sell
60,962
-15,554
-20% -$262K ﹤0.01% 1182
2019
Q3
$1.05M Buy
76,516
+4,425
+6% +$52.5K ﹤0.01% 1201
2019
Q2
$887K Buy
72,091
+2,712
+4% +$31.3K ﹤0.01% 1245
2019
Q1
$866K Buy
69,379
+895
+1% +$12K ﹤0.01% 1231
2018
Q4
$775K Buy
68,484
+1,781
+3% +$27.9K ﹤0.01% 1219
2018
Q3
$1.25M Buy
66,703
+6,399
+11% +$147K ﹤0.01% 1151
2018
Q2
$1.56M Buy
60,304
+7,020
+13% +$182K ﹤0.01% 1069
2018
Q1
$1.19M Sell
53,284
-483
-0.9% -$11.8K ﹤0.01% 1128
2017
Q4
$1.35M Buy
53,767
+6,791
+14% +$166K ﹤0.01% 1151
2017
Q3
$1.14M Sell
46,976
-8,941
-16% -$210K ﹤0.01% 1170
2017
Q2
$1.13M Buy
55,917
+338
+0.6% +$7.04K ﹤0.01% 1132
2017
Q1
$1.5M Sell
55,579
-7,906
-12% -$161K ﹤0.01% 1055
2016
Q4
$1.21M Buy
63,485
+129
+0.2% +$2.46K ﹤0.01% 1111
2016
Q3
$1.24M Sell
63,356
-93,258
-60% -$1.58M ﹤0.01% 1092
2016
Q2
$2.34M Buy
+156,614
New +$1.97M ﹤0.01% 1104
2016
Q1
Sell
-48,159
Closed -$928K 1608
2015
Q4
$928K Buy
48,159
+625
+1% +$10.9K ﹤0.01% 1093
2015
Q3
$706K Buy
+47,534
New +$1.12M ﹤0.01% 1193